Menu Close



The Swiss renal registry and quality assessment program (srrqap) was established in 2006 by the Swiss Society of Nephrology (SGN). All chronic dialysis patients in Switzerland are captured and characterized in the dialysis registry. The registry not only reflects the demographic situation and the development of the Swiss dialysis population, but also allows the assessment of important epidemiological and health policy issues prospectively. Thereby, it contributes significantly to the medical care of these patients and to gain new insights into disease mechanisms in chronic renal failure. Quality control and continuous quality improvement is another purpose, which is achieved mainly by the comparison of individual centers with Swiss benchmarks and with other countries represented in the ERA-EDTA registry. Thus, the srrqap publishes the annual figures, puts together benchmark analyses between individual centers, and submits a minimum data set to the ERA-EDTA for further comparisons.

The following parameters are assessed in the dialysis registry:

  1. Basic data: Age, gender, cause of renal failure, ethnicity, nationality, start date of renal replacement therapy, modality of renal replacement therapy, death date, death cause, kidney transplantation, type of kidney transplantation.
  2. Clinical indicators: Height, weight, amputations, actual dialysis modality, actual access, dialysis duration, blood pressure, hypertension yes/no, antihypertensive yes/no, hemoglobin, ferritin, calcium, phosphate, parathormone, iron- and EPO substitution yes/no, Kt/V.
  3. Comorbidities (yes/no): aids, chronic pulmonary disease, dementia, diabetes, hemiplegia, hepatitis B, hepatitis C, cardiac insufficiency, HIV, myocardial infarction, cardiomyopathy, collagenosis, connective tissue disease, coronary heart disease, liver disease, leukemia, lymphoma, tumor disease, metastasizing solid tumor, peripheral vascular disease, ulcer disease, cerebrovascular disease.


Last modified on March 27th, 2020 at 11:52